Table 1.
Baseline characteristics of participants
| Characteristic | All participants (n= 303) | Interview participants (n = 25) | ||
|---|---|---|---|---|
|
|
|
|||
| GP–led (n= 141) | Surgeon-led (n= 162) | GP-led (n= 17)a | Surgeon-led (n= 8) | |
| Sociodemographic | ||||
| Age, years, mean (SD) | 67.9 (8.3) | 68.2 (8.4) | 67.1 (8.4) | 59.5 (6.7) |
| Sex, male, n (%) | 98 (70) | 105 (65) | 14 (82) | 4 (50) |
| Living situation, with a partner, n (%) | 107 (76) | 120 (74) | 16 (94) | 8 (100) |
| Educational attainment, n (%) | ||||
| Primary or none | 14 (10) | 13 (8) | 1 (6) | NA |
| Secondary | 28 (20) | 40 (25) | 2 (12) | 2 (25) |
| Vocational education | 75 (53) | 71 (44) | 10 (59) | 4 (50) |
| University | 12 (9) | 24 (15) | 3 (18) | 2 (25) |
| Missing | 12 (9) | 14 (9) | 1 (6) | NA |
| Randomised to Oncokompas, n (%) | 68 (48) | 83 (51) | 10 (59) | 3 (38) |
|
| ||||
| Clinical and pathological | ||||
| Comorbidities, n (%) | ||||
| 0–1 | 63 (45) | 84 (52) | 12 (71) | 5 (63) |
| ≥2 | 78 (55) | 78 (48) | 5 (29) | 3 (38) |
| Cancer diagnosis via, n (%) | ||||
| Population screening | 74 (52) | 78 (48) | 10 (59) | 4 (50) |
| Clinical course | 67 (48) | 84 (52) | 7 (41) | 4 (50) |
| Tumour stage, n (%) | ||||
| I | 59 (42) | 54 (33) | 4 (24) | 3 (38) |
| II | 50 (35) | 54 (33) | 5 (29) | 2 (25) |
| III | 32 (23) | 54 (33) | 8 (47) | 3 (38) |
| Stoma, n (%) | 6 (4) | 7 (4) | 3 (18) | NA |
| Chemotherapy, n (%) | 27 (19) | 41 (25) | 7 (41) | 3 (38) |
| Time since surgery at moment of | NA | NA | 4.3 (3.6–5.1) | 5.0 (4.3–5.8) |
| interview, years, median (IQR) | ||||
a
During follow-up six patients transferred from the GP back to the surgeon. IQR = interquartile range. NA = not applicable.